Anti-inflammatory effect of quetiapine on collagen-induced arthritis of mouse

European Journal of Pharmacology

Volumn 678, Issue 1-3, 2012, Pages 55-60

  Kim, Hyeongseok ^a   Bang, Jihye ^a   Chang, Hyuk Won ^a   Kim, Jin Young ^a,b   Park, Keon Uk ^a,b   Kim, Sang Hyon ^a,b   Lee, Kyung Jae ^a,b   Cho, Chul Hyun ^a,b   Hwang, Ilseon ^a,b   Park, Sung Dong ^c   Ha, Eunyoung ^a   Jung, Sung Won ^a,b  

^a Keimyung University   (South Korea)

^b Dongsan Medical Center   (South Korea)

^c Dongguk University   (South Korea)

Author keywords

IL 17 (interleukin 17); IL 6 (interleukin 6); Inflammation; Quetiapine; Rheumatoid arthritis

Indexed keywords

COLLAGEN ANTIBODY; COLLAGEN TYPE 2; INTERLEUKIN 17; INTERLEUKIN 6; PROSTAGLANDIN E2; QUETIAPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIC INDEX; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; BONE EROSION; CARTILAGE INJURY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG RESPONSE; HISTOPATHOLOGY; JOINT RADIOGRAPHY; MALE; MOUSE; NONHUMAN; PAW THICKNESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WEIGHT GAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; BODY WEIGHT; BONE AND BONES; CARTILAGE; DIBENZOTHIAZEPINES; DINOPROSTONE; INTERLEUKIN-17; INTERLEUKIN-6; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; MICE, INBRED DBA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862776572     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.12.017     Document Type: Article

References (28)

1. L.A. Arvanitis, and B.G. Miller Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The seroquel trial 13 study group Biol. Psychiatry 42 1997 233 246 (Pubitemid 27325811)
2. A.D. Basterzi, C. Aydemir, C. Kisa, S. Aksaray, V. Tuzer, K. Yazici, and E. Goka IL-6 levels decrease with SSRI treatment in patients with major depression Hum. Psychopharmacol. 20 2005 473 476 (Pubitemid 41489458)
3. B.T. Baune, and H. Eyre Anti-inflammatory effects of antidepressant and atypical antipsychotic medication for the treatment of major depression and comorbid arthritis: a case report J. Med. Case Rep. 4 2010 6
4. M. Bianchi, and A.E. Panerai Antidepressant drugs and experimental inflammation Pharmacol. Res. 33 1996 235 238 (Pubitemid 26383682)
5. T.O. Bruce Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications Curr. Psychiatry Rep. 10 2008 258 264
6. G. Buchan, K. Barrett, M. Turner, D. Chantry, R.N. Maini, and M. Feldmann Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha Clin. Exp. Immunol. 73 1988 449 455
7. J. Buckland Experimental arthritis: therapeutic promise of dual blockade of IL-17 and TNF in inflammatory arthritis Nat. Rev. Rheumatol. 7 2011 311
8. N. Castanon, B.E. Leonard, P.J. Neveu, and R. Yirmiya Effects of antidepressants on cytokine production and actions Brain Behav. Immun. 16 2002 569 574 (Pubitemid 35333736)
9. C.Q. Chu, M. Field, M. Feldmann, and R.N. Maini Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis Arthritis Rheum. 34 1991 1125 1132
10. M.B. Cope, T.R. Nagy, J.R. Fernandez, N. Geary, D.E. Casey, and D.B. Allison Antipsychotic drug-induced weight gain: development of an animal model Int. J. Obes. (Lond) 29 2005 607 614 (Pubitemid 40769482)
11. M. Feldmann, F.M. Brennan, and R.N. Maini Role of cytokines in rheumatoid arthritis Annu. Rev. Immunol. 14 1996 397 440 (Pubitemid 26130190)
12. T. Hirano, T. Matsuda, M. Turner, N. Miyasaka, G. Buchan, B. Tang, K. Sato, M. Shimizu, R. Maini, and M. Feldmann Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis Eur. J. Immunol. 18 1988 1797 1801 (Pubitemid 19011590)
13. R. Holmdahl, J. Mo, C. Nordling, P. Larsson, L. Jansson, T. Goldschmidt, M. Andersson, and L. Klareskog Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms Clin. Exp. Rheumatol. 7 Suppl 3 1989 S51 S55
14. R. Holmdahl, R. Bockermann, J. Backlund, and H. Yamada The molecular pathogenesis of collagen-induced arthritis in mice-a model for rheumatoid arthritis Ageing Res. Rev. 1 2002 135 147 (Pubitemid 38344149)
15. S.Y. Hwang, J.Y. Kim, K.W. Kim, M.K. Park, Y. Moon, W.U. Kim, and H.Y. Kim IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways Arthritis Res. Ther. 6 2004 R120 R128
16. K. Komossa, C. Rummel-Kluge, F. Schmid, H. Hunger, S. Schwarz, M. Srisurapanont, W. Kissling, and S. Leucht Quetiapine versus other atypical antipsychotics for schizophrenia Cochrane Database Syst. Rev. CD006625 1 2010 134
17. T. Korn, M. Oukka, V. Kuchroo, and E. Bettelli Th17 cells: effector T cells with inflammatory properties Semin. Immunol. 19 2007 362 371 (Pubitemid 351274046)
18. M. Kubera, E. Obuchowicz, L. Goehler, J. Brzeszcz, and M. Maes In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression Prog. Neuropsychopharmacol. Biol. Psychiatry 35 2011 744 759
19. X. Li, F.L. Yuan, W.G. Lu, Y.Q. Zhao, C.W. Li, J.P. Li, and R.S. Xu The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis Biochem. Biophys. Res. Commun. 397 2010 131 135
20. E.A. Martelli, E. Toth, A.D. Segre, and N. Corsico Mechanism of inhibition of experimental inflammation by antidepressant drugs Eur. J. Pharmacol. 2 1967 229 233
21. A.M. Patel, and L.W. Moreland Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy Drug Des. Devel. Ther. 4 2010 263 278
22. S. Sacre, M. Medghalchi, B. Gregory, F. Brennan, and R. Williams Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors Arthritis Rheum. 62 2010 683 693
23. M. Taler, M. Bar, I. Korob, L. Lomnitski, E. Baharav, N. Grunbaum-Novak, A. Weizman, and I. Gil-Ad Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders Int. Immunopharmacol. 8 2008 526 533
24. M.E. Thase, W. Macfadden, R.H. Weisler, W. Chang, B. Paulsson, A. Khan, and J.R. Calabrese Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study) J. Clin. Psychopharmacol. 26 2006 600 609 (Pubitemid 44772737)
25. D.E. Trentham Collagen arthritis as a relevant model for rheumatoid arthritis Arthritis Rheum. 25 1982 911 916 (Pubitemid 12047017)
26. C.W. Tsao, Y.S. Lin, C.C. Chen, C.H. Bai, and S.R. Wu Cytokines and serotonin transporter in patients with major depression Prog. Neuropsychopharmacol. Biol. Psychiatry 30 2006 899 905
27. R.O. Williams Rodent models of arthritis: relevance for human disease Clin. Exp. Immunol. 114 1998 330 332 (Pubitemid 28539589)
28. I. Yamaguchi, K. Hamada, M. Yoshida, H. Isayama, S. Kanazashi, and K. Takeuchi Risperidone attenuates local and systemic inflammatory responses to ameliorate diet-induced severe necrotic pancreatitis in mice: it may provide a new therapy for acute pancreatitis J. Pharmacol. Exp. Ther. 328 2009 256 262